Medtronic Tests Talent For U.S. Thoracic Aortic Aneurysm Market
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is projecting that its Talent thoracic aortic aneurysm (TAA) endovascular stent graft system will gain premarket approval in late 2005
You may also be interested in...
Cook Zenith TX2 Thoracic Aortic Aneurysm Graft On Track For 2006 Launch
Cook is expanding the U.S. clinical trial of its Zenith TX2 thoracic aortic aneurysm (TAA) stent graft to include 220 patients at 35 centers, in line with FDA recommendations for patient follow-up
Cook Zenith TX2 Thoracic Aortic Aneurysm Graft On Track For 2006 Launch
Cook is expanding the U.S. clinical trial of its Zenith TX2 thoracic aortic aneurysm (TAA) stent graft to include 220 patients at 35 centers, in line with FDA recommendations for patient follow-up
Edwards Follows Guidant’s Exit From AAA Market, Seeks Lifepath Acquirer
Edwards Lifesciences' decision to suspend its Lifepath endovascular graft program accompanies a realignment of R&D priorities to cope with the rapidly maturing AAA market